Phase II double-blind randomised controlled trial of exogenous administration of melatonin in chronic pain (DREAM-CP): a study protocol.
Rosalind AdamSaravanakumar KanakarajanUzunma OnyeakaziMalachy ColumbHelen GalleyPublished in: BMJ open (2020)
ISRCTN12861060.